Literature DB >> 12693430

Motivations that maintain substance use among individuals with psychotic disorders.

Catherine Spencer1, David Castle, Patricia T Michie.   

Abstract

This study quantitatively examined reasons for substance use among individuals with psychotic disorders and explored the relationship of these reasons to substance use problems and dependence. Sixty-nine people with psychotic disorders were interviewed using a battery of questionnaires called the Substance Use Scale for Psychosis (SUSP). Symptoms and medication side effects were also measured. A factor analysis revealed similar motives for substance use (mostly alcohol and cannabis use) as in the general population: "enhancement," "social motives," "coping with unpleasant affect," and "conformity and acceptance." A fifth factor, "relief of positive symptoms and side effects," demonstrated limited reliability. "Coping" and "enhancement" motives were found to lead to substance use problems and dependence. Mediator analysis indicated that worse symptoms lead to stronger motives for substance use, which in turn lead to stronger psychological dependence on that substance. These findings have the potential to inform effective treatment for substance use in psychosis.

Entities:  

Mesh:

Year:  2002        PMID: 12693430     DOI: 10.1093/oxfordjournals.schbul.a006934

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  15 in total

1.  Perceived reasons for and consequences of substance abuse among patients with psychosis.

Authors:  Sahoo Saddichha; Ravi Prakash; Baxi N P Sinha; Christoday R J Khess
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

2.  Genetic predisposition to schizophrenia associated with increased use of cannabis.

Authors:  R A Power; K J H Verweij; M Zuhair; G W Montgomery; A K Henders; A C Heath; P A F Madden; S E Medland; N R Wray; N G Martin
Journal:  Mol Psychiatry       Date:  2014-06-24       Impact factor: 15.992

Review 3.  Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia?

Authors:  Nadia Solowij; Patricia T Michie
Journal:  J Psychiatry Neurosci       Date:  2007-01       Impact factor: 6.186

4.  Cannabis and Psychosis: What Can Daily Diaries Tell Us About Who is Vulnerable?

Authors:  David Kimhy; Kelly Durbin; Cheryl M Corcoran
Journal:  Prim psychiatry       Date:  2009

5.  Substance use after residential treatment among individuals with co-occurring disorders: the role of anxiety/depressive symptoms and trauma exposure.

Authors:  Virginia Gil-Rivas; JoAnn Prause; Christine E Grella
Journal:  Psychol Addict Behav       Date:  2009-06

Review 6.  Gene-environment interplay between cannabis and psychosis.

Authors:  Cécile Henquet; Marta Di Forti; Paul Morrison; Rebecca Kuepper; Robin M Murray
Journal:  Schizophr Bull       Date:  2008-08-22       Impact factor: 9.306

7.  Reasons for cannabis use among youths at ultra high risk for psychosis.

Authors:  Kelly E Gill; Lucy Poe; Neyra Azimov; Shelly Ben-David; Nehal P Vadhan; Ragy Girgis; Holly Moore; Victoria Cressman; Cheryl M Corcoran
Journal:  Early Interv Psychiatry       Date:  2013-11-26       Impact factor: 2.732

8.  Reasons for illicit drug use in people with schizophrenia: Qualitative study.

Authors:  Carolyn J Asher; Linda Gask
Journal:  BMC Psychiatry       Date:  2010-11-22       Impact factor: 3.630

9.  Cannabis and psychosis: what causes what?

Authors:  David J Castle
Journal:  F1000 Med Rep       Date:  2013-01-11

10.  Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study.

Authors:  I Harrison; E M Joyce; S H Mutsatsa; S B Hutton; V Huddy; M Kapasi; T R E Barnes
Journal:  Psychol Med       Date:  2007-05-29       Impact factor: 7.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.